ÂÒÂ×Ðã

The JRO supports on average 130 new studies to sponsorship and regulatory approvals per year. This includes support from JRO expertise in regulatory submissions, protocol development and in research design, costing and contracting. This includes advice on data sharing, Intellectual property, medicinal products, pharmacovigilence, patient and public advice and collaborations with external parties.

The JRO also supports on average 300 studies new studies to open at ÂÒÂ×ÐãH per year. Its support includes feasibility assessments, costings and contracting. The JRO also works alongside key service support departments at ÂÒÂ×ÐãH to ensure adequate support, facilities and staff are in place to efficiently open and deliver studies.

Click here to find out more about the research which is happening atÌý.

Ìý

The JRO provides assurance to ÂÒÂ×Ðã and ÂÒÂ×ÐãH about the research portfolio. This includes auditing and monitoring, responding to incidents and supporting regulatory inspections and audits. The JRO also manages the ÂÒÂ×Ðã Sponsor Oversight Committee (SOC), and reports and/or advises on research matters to the ÂÒÂ×Ðã Clinical Research Governance Committee and to relevant ÂÒÂ×Ðã and ÂÒÂ×ÐãH Boards and Committees.

The JRO also provides a range of training opportunities to researchers - ranging from GCP through to bespoke sessions on IRAS and drop-in sessions for researchers to ask questions about regulations and systems.

The JRO supports ÂÒÂ×Ðã and ÂÒÂ×ÐãH in its strategies to grow the portfolio of clinical research. It works alongside the BRC and key groups within ÂÒÂ×ÐãH and ÂÒÂ×Ðã to ensure systems are in place toÌý maximize performance and delivery of the research portfolio. The JRO expertise in financial management, IP and legal matters support the set-up of collaborations with industry and other external partners. The JRO data performance and finance teams produce regular activity and performance reports to inform future growth plans and assess performance against targets and requirements.

The JRO, through its partnering with the BRC, provides expert advice on Patient and Public involvement for researchers at ÂÒÂ×Ðã and ÂÒÂ×ÐãH. It's activities include practical advice, training for researchers and opportunities for patients and the public to become part of research networks. The PPI team within the JRO/BRC also run annual research open days at ÂÒÂ×ÐãH for patients to be able to interact with some of the most cutting edge and innovate research technologies and studies at ÂÒÂ×ÐãH.Ìý

The JRO works with a network of experts and services across ÂÒÂ×Ðã and ÂÒÂ×ÐãH to deliver quality and seamless research expertise. It is heavily involved with, and drives, research policy developments across ÂÒÂ×Ðã and ÂÒÂ×ÐãH and represents the clinical research portfolio at committees and boards within ÂÒÂ×Ðã and ÂÒÂ×ÐãH, as well as input to national consultations and policy matters.

As a University,Ìý ÂÒÂ×Ðã uses personally-identifiable information to conduct research to improve health, care and services. As a publicly-funded organisation, we have to ensure that it is in the public interest when we use personally-identifiable information from people who have agreed to take part in research. To read the full statement please visit ourÌýData Protection page.ÌýÌýÌýÌý